Patient-reported perceptions of brexanolone in the treatment of postpartum depression: A qualitative analysis.

Aaron Salwan Megan E Maroney Lisa Tremayne

Published in: The mental health clinician (2023)

Brexanolone rapidly and sustainably reduced symptoms of PPD and was well-received by patients. Despite significant barriers to use, women who received treatment with brexanolone advocated for its availability as well as increased awareness of PPD.

Keyphrases

patient reported
end stage renal disease
healthcare
ejection fraction
primary care
depressive symptoms
chronic kidney disease
sleep quality
combination therapy
metabolic syndrome